
Ulotaront (SEP-363856, SEP-856) is a novel psychotropic agent with agonism at trace amine рецептор 1 (TAAR1) and 5-HT1A receptors but no appreciable action at dopamine D2 receptors.Ulotaront significantly reduced the ketamine-induced increase in dopamine synthesis capacity.
Ulotaront (SEP-363856, SEP-856) is a novel psychotropic agent with agonism at trace amine receptor 1 (TAAR1) and 5-HT1A receptors but no appreciable action at dopamine D2 receptors.Ulotaront significantly reduced the ketamine-induced increase in dopamine synthesis capacity.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.